|
PHF12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.447800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.056150E-01 |
| Normal-vs-Stage2 |
8.466400E-01 |
| Normal-vs-Stage3 |
6.603200E-01 |
| Normal-vs-Stage4 |
8.608600E-01 |
| Stage1-vs-Stage2 |
1.006790E-01 |
| Stage1-vs-Stage3 |
1.546580E-01 |
| Stage1-vs-Stage4 |
5.499700E-02 |
| Stage2-vs-Stage3 |
5.546200E-01 |
| Stage2-vs-Stage4 |
9.545400E-01 |
| Stage3-vs-Stage4 |
5.177000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.246800E-01 |
| Normal-vs-AfricanAmerican |
8.453600E-02 |
| Normal-vs-Asian |
1.657860E-03 |
| Caucasian-vs-AfricanAmerican |
8.144200E-02 |
| Caucasian-vs-Asian |
6.117100E-03 |
| AfricanAmerican-vs-Asian |
9.994300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.602800E-01 |
| Normal-vs-Female |
3.717900E-02 |
| Male-vs-Female |
1.157840E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.476200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.318770E-01 |
| Normal-vs-Age(61-80Yrs) |
5.839000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.132400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.278000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.783000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.783000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.760430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.176990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.305800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.657000E-03 |
| Normal-vs-Grade 2 |
9.057800E-02 |
| Normal-vs-Grade 3 |
9.515200E-01 |
| Normal-vs-Grade 4 |
3.745000E-01 |
| Grade 1-vs-Grade 2 |
4.095700E-03 |
| Grade 1-vs-Grade 3 |
1.960460E-04 |
| Grade 1-vs-Grade 4 |
2.120000E-03 |
| Grade 2-vs-Grade 3 |
2.291900E-02 |
| Grade 2-vs-Grade 4 |
5.507800E-01 |
| Grade 3-vs-Grade 4 |
2.658000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.533840E-01 |
| Normal-vs-ccB subtype |
2.935000E-01 |
| ccA subtype-vs-ccB subtype |
7.276800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.298600E-01 |
| Normal-vs-N1 |
1.529630E-01 |
| N0-vs-N1 |
3.848800E-01 |
|
|
